INVESTMENT: THE FRENCH SGAM FOUNDATION AWARDS FUNDS TO EARLY STAGE FROM SCRATCH

Stepping in relatively early, so as not to miss any business, but not too early, thus reducing the risk and the time of return on investment, that is the art of ideal timing for investment in biotech, and it's far from easy. And while the general trend in Europe is to invest at the latest stage possible, the Société Générale Asset Management (SGAM) is breaking this habit by supporting programs from scratch through its Foundation for Therapeutic Innovation...

More...

NORTH CAROLINA - ALSACE: A NEW BIOMANUFACTURING ALLIANCE

Nicolas Carboni

The Alsace Biovalley cluster, the renowned European specialist in biomanufacturing and aseptic production, has just reached an important milestone in its specialty by announcing an agreement between the University of Strasbourg in France and the Biomanufacturing Training and Education Center (BTEC) of the North Carolina State University. These two academic institutions will collaborate on a unique...

More...